Catalyst Pharmaceuticals Inc (CPRX)
21.74
-0.15
(-0.69%)
USD |
NASDAQ |
Nov 04, 16:00
21.76
+0.02
(+0.09%)
Pre-Market: 08:48
Catalyst Pharmaceuticals Cash from Investing (Quarterly): -0.01M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.01M |
| March 31, 2024 | -0.199M |
| December 31, 2023 | -38.32M |
| September 30, 2023 | -92.82M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -162.37M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.132M |
| June 30, 2022 | 9.341M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -0.041M |
| September 30, 2021 | -0.068M |
| June 30, 2021 | -4.001M |
| March 31, 2021 | -6.911M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | -10.01M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 5.00M |
| December 31, 2019 | 31.66M |
| September 30, 2019 | 5.047M |
| June 30, 2019 | -9.931M |
| March 31, 2019 | 10.45M |
| December 31, 2018 | 14.14M |
| September 30, 2018 | 7.577M |
| June 30, 2018 | -4.955M |
| Date | Value |
|---|---|
| March 31, 2018 | -31.85M |
| December 31, 2017 | 0.0608M |
| September 30, 2017 | -0.0298M |
| June 30, 2017 | -0.0018M |
| March 31, 2017 | -0.0331M |
| December 31, 2016 | 0.5865M |
| September 30, 2016 | 2.199M |
| June 30, 2016 | 0.8327M |
| March 31, 2016 | -0.0656M |
| December 31, 2015 | 0.0505M |
| September 30, 2015 | -0.0444M |
| June 30, 2015 | 0.0307M |
| March 31, 2015 | -0.0433M |
| December 31, 2014 | -0.0089M |
| September 30, 2014 | 0.0151M |
| June 30, 2014 | -10.01M |
| March 31, 2014 | 1.265M |
| December 31, 2013 | -6.806M |
| September 30, 2013 | -4.197M |
| June 30, 2013 | 2.022M |
| March 31, 2013 | 1.485M |
| December 31, 2012 | -14.05M |
| September 30, 2012 | -0.00 |
| June 30, 2012 | -0.0019M |
| March 31, 2012 | -0.005M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-162.37M
Minimum
Mar 2023
31.66M
Maximum
Dec 2019
-14.15M
Average
-0.041M
Median
Dec 2021
Cash from Investing (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | -98.53M |
| Vertex Pharmaceuticals Inc | -463.70M |
| Regenxbio Inc | -0.268M |
| Edgewise Therapeutics Inc | 37.37M |
| Entrada Therapeutics Inc | -24.38M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 64.14M |
| Cash from Financing (Quarterly) | 1.157M |
| Free Cash Flow | 114.96M |
| Free Cash Flow Per Share (Quarterly) | 0.5144 |
| Free Cash Flow to Equity (Quarterly) | 64.12M |
| Free Cash Flow to Firm (Quarterly) | 64.12M |
| Free Cash Flow Yield | 4.52% |